[HTML][HTML] Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects

G Lisco, A De Tullio, E Jirillo, VA Giagulli… - Journal of …, 2021 - Springer
Background Thyroid dysfunction has been observed in patients with COVID-19, and
endocrinologists are requested to understand this clinical issue. Pandemic-related …

Coronavirus disease 2019 as cause of viral sepsis: a systematic review and meta-analysis

E Karakike, EJ Giamarellos-Bourboulis… - Critical care …, 2021 - journals.lww.com
Objective: Coronavirus disease 2019 is a heterogeneous disease most frequently causing
respiratory tract infection, which can induce respiratory failure and multiple organ …

Anticoagulants for people hospitalised with COVID‐19

RLG Flumignan, VT Civile… - Cochrane Database …, 2022 - cochranelibrary.com
Background The primary manifestation of coronavirus disease 2019 (COVID‐19) is
respiratory insufficiency that can also be related to diffuse pulmonary microthrombosis and …

[HTML][HTML] Síndrome post-COVID: Un documento de reflexión y opinión

E Bouza, RC Moreno, PDL Ramos… - Revista española de …, 2021 - ncbi.nlm.nih.gov
Un elevado porcentaje de las personas que han padecido COVID refieren, tras la
recuperación de la fase aguda de la enfermedad, una serie de manifestaciones clínicas …

Atrial fibrillation occurring during acute hospitalization: a scientific statement from the American Heart Association

JY Chyou, E Barkoudah, JW Dukes, LB Goldstein… - Circulation, 2023 - Am Heart Assoc
Acute atrial fibrillation is defined as atrial fibrillation detected in the setting of acute care or
acute illness; atrial fibrillation may be detected or managed for the first time during acute …

Use of aspirin in reduction of mortality of COVID‐19 patients: A meta‐analysis

R Srivastava, A Kumar - International journal of clinical practice, 2021 - Wiley Online Library
COVID‐19 infection, affecting every one of us from the last year. Emerging reports have
indicated thromboembolism in serious cases of COVID‐19. The aspirin is useful to reduce …

[HTML][HTML] Thromboplasminflammation in COVID-19 coagulopathy: three viewpoints for diagnostic and therapeutic strategies

S Gando, T Wada - Frontiers in Immunology, 2021 - frontiersin.org
Thromboplasminflammation in coronavirus disease 2019 (COVID-19) coagulopathy consists
of angiotensin II (Ang II)-induced coagulopathy, activated factor XII (FXIIa)-and kallikrein …

[HTML][HTML] Does aspirin have an effect on risk of death in patients with COVID-19? A meta-analysis

S Ma, W Su, C Sun, S Lowe, Z Zhou, H Liu… - European Journal of …, 2022 - Springer
Purpose The coronavirus disease 2019 (COVID-19) pandemic has shown unprecedented
impact world-wide since the eruption in late 2019. Importantly, emerging reports suggest an …

Post-COVID syndrome: A reflection and opinion paper.

E Bouza, MC Martín Delgado, M Santos Sebastián - 2021 - ddfv.ufv.es
Un elevado porcentaje de las personas que han padecido COVID refieren, tras la
recuperación de la fase aguda de la enfermedad, una serie de manifestaciones clínicas …

Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19

AK Pasha, RD McBane, R Chaudhary, LJ Padrnos… - Thrombosis research, 2021 - Elsevier
Background The reported incidence of venous thromboembolism (VTE) in COVID-19
patients varies widely depending on patient populations sampled and has been …